These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3801905)

  • 21. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic and radioimmunologic activity of cholecystokinin in regions of mammalian brains.
    Simon-Assmann PM; Yazigi R; Greeley GH; Rayford PL; Thompson JC
    J Neurosci Res; 1983; 10(2):165-73. PubMed ID: 6313953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of cholecystokinin receptors on the sphincter of Oddi.
    Cox KL; von Schrenck T; Moran TH; Gardner JD; Jensen RT
    Am J Physiol; 1990 Nov; 259(5 Pt 1):G873-81. PubMed ID: 2240227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression, but failing maturation of procholecystokinin in cerebellum.
    Rehfeld JF; Mogensen NW; Bardram L; Hilsted L; Monstein HJ
    Brain Res; 1992 Mar; 576(1):111-9. PubMed ID: 1515904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo studies on the basal and evoked release of cholecystokinin and vasoactive intestinal polypeptide from cat cerebral cortex and periventricular structures.
    Wang JY; Yaksh TL; Go VL
    Brain Res; 1983 Nov; 280(1):105-17. PubMed ID: 6652473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioreceptor and biological characterization of cholecystokinin and gastrin in the chicken.
    Vigna SR
    Am J Physiol; 1984 Mar; 246(3 Pt 1):G296-304. PubMed ID: 6703057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [3H]pBC 264, a suitable probe for studying cholecystokinin-B receptors: binding characteristics in rodent brains and comparison with [3H]SNF 8702.
    Durieux C; Ruiz-Gayo M; Corringer PJ; Bergeron F; Ducos B; Roques BP
    Mol Pharmacol; 1992 Jun; 41(6):1089-95. PubMed ID: 1614411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of a large cholecystokinin precursor from canine brain.
    Eysselein VE; Reeve JR; Shively JE; Miller C; Walsh JH
    Proc Natl Acad Sci U S A; 1984 Nov; 81(21):6565-8. PubMed ID: 6093106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin in the central nervous system.
    Beinfeld MC; Meyer DK; Brownstein MJ
    Peptides; 1981; 2 Suppl 2():77-9. PubMed ID: 6283500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cholecystokinin octapeptide sulphate ester on brain monoamines in the rat.
    Fekete M; Várszegi M; Kádár T; Penke B; Kovács K; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 57(1):37-46. PubMed ID: 6269350
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitation and identification of two cholecystokinin peptides, CCK-4 and CCK-8s, in rat brain by HPLC and fast atom bombardment mass spectrometry.
    Qureshi GA; Bednar I; Min Q; Södersten P; Silberring J; Nyberg F; Thörnwall M
    Biomed Chromatogr; 1993; 7(5):251-5. PubMed ID: 8305854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of cholecystokinin-like peptides in the human-brain.
    Emson PC; Rehfeld JF; Rossor MN
    J Neurochem; 1982 Apr; 38(4):1177-9. PubMed ID: 7062038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride.
    Kessler RM; Whetsell WO; Ansari MS; Votaw JR; de Paulis T; Clanton JA; Schmidt DE; Mason NS; Manning RG
    Brain Res; 1993 Apr; 609(1-2):237-43. PubMed ID: 8099521
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of tissue cholecystokinin (CCK) concentrations by bioassay and specific radioimmunoassay: characterization of the bioactivity of CCK-58 before and after tryptic cleavage.
    Höcker M; Schmidt WE; Wilms HM; Lehnhoff F; Nustede R; Schafmayer A; Fölsch UR
    Eur J Clin Invest; 1990 Oct; 20 Suppl 1():S45-50. PubMed ID: 2124997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exogenous cholecystokinin (CCK) reduces neonatal rat brain opioid receptor density and CCK levels.
    Johnson FE; Hudd C; LaRegina MC; Beinfeld MC; Tolbert DL; Spain JW; Szucs M; Coscia CJ
    Brain Res; 1987 Mar; 429(1):139-46. PubMed ID: 3032370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of cholecystokinin from the human brain.
    Miller LJ; Jardine I; Weissman E; Go VL; Speicher D
    J Neurochem; 1984 Sep; 43(3):835-40. PubMed ID: 6086839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Localization of cholecystokinin binding sites in canine brain using quantitative autoradiography.
    Morency MA; Quirion R; Nair NP; Mishra RK
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(2):291-6. PubMed ID: 1871331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A.
    Migaud M; Durieux C; Viereck J; Soroca-Lucas E; Fournié-Zaluski MC; Roques BP
    Peptides; 1996; 17(4):601-7. PubMed ID: 8804068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay.
    Beinfeld MC; Meyer DK; Eskay RL; Jensen RT; Brownstein MJ
    Brain Res; 1981 May; 212(1):51-7. PubMed ID: 7225864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.